(Q36337354)

English

Effect of 4 years of growth hormone therapy in children with Noonan syndrome in the American Norditropin Studies: Web-Enabled Research (ANSWER) Program® registry

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Effect of 4 years of growth hormone therapy in children with Noonan syndrome in the American Norditropin Studies: Web-Enabled Research (ANSWER) Program® registry (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Noonan syndrome

1 reference

based on heuristic

inferred from title

Peter Allen Lee

1

object named as

Peter A Lee

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

Judith Ross

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

John A Germak

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Robert Gut

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

publication date

8 June 2012

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

International journal of pediatric endocrinology

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

2012

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

15

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

8 June 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Factors influencing the one- and two-year growth response in children treated with growth hormone: analysis from an observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477766

30 September 2017

Noonan syndrome: clinical features, diagnosis, and management guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477766

30 September 2017

Noonan syndrome: clinical aspects and molecular pathogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477766

30 September 2017

GH therapy in Noonan syndrome: Review of final height data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477766

30 September 2017

Growth hormone treatment in children with Noonan's syndrome: four year results of a partly controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477766

30 September 2017

Short stature in Noonan syndrome: response to growth hormone therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477766

30 September 2017

Response to growth hormone in short children with Noonan syndrome: correlation to genotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477766

29 June 2018

Noonan syndrome: growth to growth hormone - the experience of observational studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477766

29 June 2018

Noonan syndrome: growth and clinical manifestations in 144 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477766

29 June 2018

Improved final height with long-term growth hormone treatment in Noonan syndrome

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2012-15

21 January 2018

Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2012-15

21 January 2018

Growth hormone therapy and growth in children with Noonan's syndrome: results of 3 years' follow-up.

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2012-15

21 January 2018

Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11.

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2012-15

21 January 2018

Clinical evaluation of recombinant human growth hormone in Noonan syndrome

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2012-15

21 January 2018

PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome.

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2012-15

21 January 2018

PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2012-15

21 January 2018

Noonan syndrome: relationships between genotype, growth, and growth factors

1 reference

https://api.crossref.org/works/10.1186%2F1687-9856-2012-15

21 January 2018

Response to growth hormone treatment and final height in Noonan syndrome in a large cohort of patients in the KIGS database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3477766

22 September 2018

Growth hormone therapy in pre-pubertal children with Noonan syndrome: first year growth response and comparison with Turner syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22682146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth hormone (GH) secretion in children with Noonan syndrome: frequently abnormal without consequences for growth or response to GH treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/22682146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children--2003 update

1 reference

https://pubmed.ncbi.nlm.nih.gov/22682146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth in Noonan syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22682146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth hormone treatment in Noonan syndrome: the National Cooperative Growth Study experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/22682146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1687-9856-2012-15

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36337354&oldid=2198706187"